Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Recent progress in systemic treatment for lung cancer.

Current opinion in pulmonary medicine - 1 Jul 2018

Clark Jeffrey W, Longo Dan L

Abstract excerpt

PURPOSE OF REVIEW: We intend to highlight progress made in 2017 to lung cancer molecular nosology and application of new knowledge to treatment. RECENT FINDINGS: Studies have shown that agents targeting specific molecular defects in lung cancers such as epidermal growth factor receptor(egfr) mutations, alk or ros1 gene rearrangements, are more effective than conventional combination chemotherapy as primary...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anaplastic Lymphoma Kinase
Share to Antineoplastic Agents, Immunological
Share to Drug Resistance, Neoplasm

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Immunotherapy

Share to Molecular Targeted Therapy

Share to Protein-Tyrosine Kinases

Share to Proto-Oncogene Proteins p21(ras)

Share to Small Cell Lung Carcinoma

Source

Identifiers

PMID: 29697418
DOI: 10.1097/MCP.0000000000000493

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Recent progress in systemic treatment for lung cancer.PMID 29697418Read ↗

Personalized therapy for lung cancer: striking a moving target.Semantic proximity Read ↗

Targeted therapies and immunotherapy in non-small-cell lung cancerSemantic proximity Read ↗

Current Landscape of Targeted Therapy in Lung Cancer.Semantic proximity Read ↗

Targeted therapy for non-small-cell lung cancer: past, present and future.Semantic proximity Read ↗

Systemic Therapy for Mutation-Driven NSCLC.Semantic proximity Read ↗

Lung Cancer Genomics in the Era of Accelerated Targeted Drug Development.Semantic proximity Read ↗

Emerging application of genomics-guided therapeutics in personalized lung cancer treatmentSemantic proximity Read ↗

Clinical testing for molecular targets for personalized treatment in lung cancer.Semantic proximity Read ↗

From Biology to Therapy: Improvements of Therapeutic Options in Lung Cancer.Semantic proximity Read ↗

Personalized targeted therapy for lung cancer.Semantic proximity Read ↗

Metastatic Lung Cancer: Emerging Therapeutic Strategies.Semantic proximity Read ↗

Personalized treatment of lung cancer.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.